Symrise AG (FRA:SY1)
Market Cap | 11.10B |
Revenue (ttm) | 4.99B |
Net Income (ttm) | 506.93M |
Shares Out | n/a |
EPS (ttm) | 3.63 |
PE Ratio | 21.90 |
Forward PE | 19.71 |
Dividend | 1.20 (1.49%) |
Ex-Dividend Date | May 21, 2025 |
Volume | 32,742 |
Average Volume | 358,699 |
Open | 80.34 |
Previous Close | 80.32 |
Day's Range | 80.20 - 80.84 |
52-Week Range | 77.46 - 125.00 |
Beta | n/a |
RSI | 28.11 |
Earnings Date | Jul 30, 2025 |
About Chimerix
Symrise AG operates as a supplier of fragrances, flavorings, cosmetic base materials and active ingredients, and functional ingredients and solutions in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. The company operates in two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, ba... [Read more]
Financial Performance
In 2024, Symrise AG's revenue was 5.00 billion, an increase of 5.67% compared to the previous year's 4.73 billion. Earnings were 478.22 million, an increase of 40.46%.
Financial StatementsNews

EQS-DD: Symrise AG: Harald Feist, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.08.2025 / 11:51 CET/CEST The issuer is solely responsi...

EQS-DD: Symrise AG: Olaf Klinger, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 31.07.2025 / 11:24 CET/CEST The issuer is solely responsi...

EQS-DD: Symrise AG: Michael König, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 31.07.2025 / 11:20 CET/CEST The issuer is solely responsi...
Symrise AG 2025 Q2 - Results - Earnings Call Presentation

Symrise AG (SYIEF) H1 2025 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) H1 2025 Earnings Call July 30, 2025 5:00 AM ET Company Participants Jean-Yves Parisot - CEO, Head of Scent & Care and Member of Executive Board Olaf Klinger - CFO, Head of Fin...

EQS-DD: Symrise AG: Dr. Stephanie Coßmann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 30.07.2025 / 13:56 CET/CEST The issuer is solely responsi...

Symrise Shines: H1 2025 Results Revealed!
Symrise navigates 2025 with strategic agility, reporting a 3.1% organic growth and €2,554 million in revenue, while enhancing efficiency and profitability. Jetzt den vollständigen Artikel lesen

EQS-News: Michael Friede has been appointed Symrise Executive Board Member and President Scent & Care
EQS-News: Symrise AG / Key word(s): Personnel Michael Friede has been appointed Symrise Executive Board Member and President Scent & Care 30.07.2025 / 07:35 CET/CEST The issuer is solely responsible f...

EQS-News: Symrise Reports First Half 2025 Results
EQS-News: Symrise AG / Key word(s): Half Year Report/Half Year Results Symrise Reports First Half 2025 Results 30.07.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this anno...

EQS-AFR: Symrise AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: Symrise AG / Preliminary announcement on the disclosure of financial statements Symrise AG: Preliminary announcement of the publication of quarterly rep...

EQS-AFR: Symrise AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Symrise AG / Preliminary announcement on the disclosure of financial statements Symrise AG: Preliminary announcement of the publication of financial rep...

EQS-DD: Symrise AG: Dr. Stephanie Coßmann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.06.2025 / 16:47 CET/CEST The issuer is solely responsi...

EQS-DD: Symrise AG: Walter Ribeiro, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 26.06.2025 / 18:01 CET/CEST The issuer is solely responsi...

EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Symrise AG Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 30.04.2...

Symrise Shines: Strong Q1 Growth & Steady Outlook
Symrise kicks off 2025 with a robust start, achieving a notable 4.2% organic growth in Q1. With sales soaring to €1.3 billion, the company confidently reaffirms its ambitious 2025 targets. The Taste, ...

EQS-News: Symrise delivers solid growth in Q1 and reaffirms outlook
EQS-News: Symrise AG / Key word(s): Sales Result/Quarter Results Symrise delivers solid growth in Q1 and reaffirms outlook 29.04.2025 / 07:30 CET/CEST The issuer is solely responsible for the content ...

EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Symrise AG Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 31.03.2...

Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
HBC will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in Berkåk, Norway. Symrise will support the financing of the project through a...

Symrise AG (SYIEF) Q3 2024 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q3 2024 Earnings Conference Call October 24, 2024 2:00 AM ET Company Participants Jean-Yves Parisot - President, Taste Nutrition & Health & Incoming CEO Olaf Klinger - CFO Con...

Symrise AG (SYIEF) Q2 2024 Earnings Call Transcript
Start Time: 05:00 January 1, 0000 6:03 AM ET Symrise AG (OTCPK:SYIEF) Q2 2024 Earnings Conference Call August 01, 2024, 05:00 AM ET Company Participants Olaf Klinger - Chief Financial Officer Jean-Yve...

Symrise AG (SYIEF) Q4 2023 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q4 2023 Earnings Conference Call March 6, 2024 7:00 AM ET Company Participants Tobias Erfurth - Head, Investor Relations Heinz-Jurgen Bertram - Chief Executive Officer Olaf Kl...

European Dividend Gems: Symrise AG
Symrise is one of the top players in the highly concentrated aroma molecules, flavours, and fragrances market. Ingredients from this company are used in products we use on a daily basis, resulting in ...

Symrise AG (SYIEF) Q4 2022 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q4 2022 Earnings Conference Call March 8, 2023 7:00 AM ET Company Participants Tobias Erfurth - Head, IR Heinz-Jurgen Bertram - CEO Stephanie Cossmann - Human Resources and Le...

Symrise AG (SYIEF) CEO Dr. Heinz-Jürgen Bertram on Q4 2021 Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Dr. Heinz-Jürgen Bertram on Q4 2021 Results - Earnings Call Transcript

Symrise AG (SYIEF) CEO Heinz-Jürgen Bertram on Q2 2021 Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Heinz-Jürgen Bertram on Q2 2021 Results - Earnings Call Transcript